Aaron Lovelace

Providing a new standard-of-care in coagulation diagnostics. Modernized coagulation testing that can characterize patient physiological data such as anticoagulants, ethnicity and care history. Existing tests such as PT/INR do not provide the sensitivity or depth of information needed in critical care applications such as traumatic injury or surgical monitoring. Simple to use, mobile and inexpensive; iFirst’s “mobile lab” will enable lifesaving information to be transmitted to the hospital prior to patient arrival. Blood products can be selected as the patient is en-route. iFirst envisions the growth of products using a mobile health diagnostic platform and continues to pursue its application for other critical situations; where ease of use, cost, and mobility can help save lives of patients and provide care-providers increase profits.

LifeDNA—a pioneering personal genomics company—offers DNA-personalized reports, insights, and actionable suggestions to help people unlock the power of their DNA. LifeDNA has sold a majority interest in LifeDNA to Rhyz Inc., investment arm of Nu Skin Enterprises (NYSE: NUS), a global leader in beauty and wellness. Together, we believe that personalization in the beauty, wellness, and lifestyle space will deepen over time to the genetic level. DNA will become an increasingly important source of information for people to understand their personal care and wellness needs that can influence the quality and longevity of their lives. We are just getting started in this exciting partnership and look forward to sharing more in the future. MISSION LifeDNAs mission is to inspire people to unlock the power of their DNA so they can live healthier, more fulfilling lives. Facebook, Instagram, Twitter: @golifedna http://www.lifedna.com/

Providing a new standard-of-care in coagulation diagnostics. Modernized coagulation testing that can characterize patient physiological data such as anticoagulants, ethnicity and care history. Existing tests such as PT/INR do not provide the sensitivity or depth of information needed in critical care applications such as traumatic injury or surgical monitoring. Simple to use, mobile and inexpensive; iFirst’s “mobile lab” will enable lifesaving information to be transmitted to the hospital prior to patient arrival. Blood products can be selected as the patient is en-route. iFirst envisions the growth of products using a mobile health diagnostic platform and continues to pursue its application for other critical situations; where ease of use, cost, and mobility can help save lives of patients and provide care-providers increase profits.

LifeDNA—a pioneering personal genomics company—offers DNA-personalized reports, insights, and actionable suggestions to help people unlock the power of their DNA. LifeDNA has sold a majority interest in LifeDNA to Rhyz Inc., investment arm of Nu Skin Enterprises (NYSE: NUS), a global leader in beauty and wellness. Together, we believe that personalization in the beauty, wellness, and lifestyle space will deepen over time to the genetic level. DNA will become an increasingly important source of information for people to understand their personal care and wellness needs that can influence the quality and longevity of their lives. We are just getting started in this exciting partnership and look forward to sharing more in the future. MISSION LifeDNAs mission is to inspire people to unlock the power of their DNA so they can live healthier, more fulfilling lives. Facebook, Instagram, Twitter: @golifedna http://www.lifedna.com/

BeeStripe creates products that help people improve their everyday online lives. Product focuses include privacy-enhancement, security, and shopping.

Speekit is a language learning company dedicated to providing fun, effective learning alternatives.